As modern biotechnologies advance, it has become increasingly frequent that different modalities of high-dimensional molecular data (termed “omics” data in this paper), such as gene expression, methylation, and copy number, are collected from the same patient cohort to predict the clinical outcome. While prediction based on omics data has been widely studied in the last fifteen years, little has been done in the statistical literature on the integration of multiple omics modalities to select a subset of variables for prediction, which is a critical task in personalized medicine. In this paper, we propose a simple penalized regression method to address this problem by assigning different penalty factors to different data modalities for featu...
An important application of microarray technology is to relate gene expression profiles to various c...
In clinical trials, identification of prognostic and predictive biomarkers is essential to precision...
Over the last decades, molecular signatures have become increasingly important in oncology and are o...
As modern biotechnologies advance, it has become increasingly frequent that different modalities of ...
Abstract Background The inclusion of high-dimensional omics data in prediction models has become a w...
Large‐scale in vitro drug sensitivity screens are an important tool in personalized oncology to pred...
International audienceMotivation:It is more and more common to explore the genome at diverse levels ...
International audienceBackground: Prediction of patient survival from tumor molecular ‘-omics’ data ...
International audienceBACKGROUND: The standard lasso penalty and its extensions are commonly used to...
Accurate prognosis of patients with cancer is important for the stratification of patients, the opti...
Developments in high-throughput technology have made multi-omics data available on a large scale. Mu...
Abstract Discovery of robust diagnostic or prognostic biomarkers is a key to optimizing therapeutic ...
Covariate selection is a fundamental step when building sparse prediction models in order to avoid o...
With the rise of high throughput technologies in biomedical research, large volumes of expression pr...
With the rise of high throughput technologies in biomedical research, large volumes of expression pr...
An important application of microarray technology is to relate gene expression profiles to various c...
In clinical trials, identification of prognostic and predictive biomarkers is essential to precision...
Over the last decades, molecular signatures have become increasingly important in oncology and are o...
As modern biotechnologies advance, it has become increasingly frequent that different modalities of ...
Abstract Background The inclusion of high-dimensional omics data in prediction models has become a w...
Large‐scale in vitro drug sensitivity screens are an important tool in personalized oncology to pred...
International audienceMotivation:It is more and more common to explore the genome at diverse levels ...
International audienceBackground: Prediction of patient survival from tumor molecular ‘-omics’ data ...
International audienceBACKGROUND: The standard lasso penalty and its extensions are commonly used to...
Accurate prognosis of patients with cancer is important for the stratification of patients, the opti...
Developments in high-throughput technology have made multi-omics data available on a large scale. Mu...
Abstract Discovery of robust diagnostic or prognostic biomarkers is a key to optimizing therapeutic ...
Covariate selection is a fundamental step when building sparse prediction models in order to avoid o...
With the rise of high throughput technologies in biomedical research, large volumes of expression pr...
With the rise of high throughput technologies in biomedical research, large volumes of expression pr...
An important application of microarray technology is to relate gene expression profiles to various c...
In clinical trials, identification of prognostic and predictive biomarkers is essential to precision...
Over the last decades, molecular signatures have become increasingly important in oncology and are o...